MedPharm
This person does not yet have a bio.Content by MedPharm
| 4 min read
The regulatory landscape governing the approval of generic topical products is changing on both sides of the Atlantic, and the senior vice president of business development for MedPharm talks about what this means in terms of in-vitro release testing and in-vitro permeation testing models and other issues
Page 1 of 1 - 1 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe